Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

Antigenic differences between Omicron BA.1 and BA.2 SARS-CoV-2 variants

2 Mar 2022
Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

Short-term change of depressive and anxiety symptoms in relation to COVID-19 vaccination

2 Mar 2022
Potential of a SARS-CoV-2 immunoPET approach to study COVID-19 dynamics in total body in rhesus macaques

Potential of a SARS-CoV-2 immunoPET approach to study COVID-19 dynamics in total body in rhesus macaques

2 Mar 2022
Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

Serological test to assess presence of immunoglobulin isotypes targeted against antigens routinely used in COVID-19 diagnosis

2 Mar 2022
Understanding the evolutionary mutational patterns of chronic SARS-CoV-2 infection

Understanding the evolutionary mutational patterns of chronic SARS-CoV-2 infection

2 Mar 2022
Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

Study reports substantial loss of protection one month after complete SARS-CoV-2 BNT162b2 immunization in children

2 Mar 2022
Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

Population-level health and economic impact of the Pfizer-BioNTech COVID-19 vaccine in first year of rollout in the US

2 Mar 2022
More evidence points to the Wuhan Market as a source of the COVID-19 pandemic

More evidence points to the Wuhan Market as a source of the COVID-19 pandemic

2 Mar 2022
A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

A ubiquitous protein may be key to the survival of neurons most impacted by glaucoma

1 Mar 2022
mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

mRNA vaccines found to generate neutralizing antibodies against SARS-CoV-2 Omicron variant

1 Mar 2022
Risk of death involving COVID-19 following infection from Omicron relative to Delta

Risk of death involving COVID-19 following infection from Omicron relative to Delta

1 Mar 2022
Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

Exploring Oxford nanopore technology-based on-site SARS-CoV-2 genome sequencing

1 Mar 2022
Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

Impact of COVID-19 boosters on protection against SARS-CoV-2 infection in a highly vaccinated population

1 Mar 2022
Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

Association between booster breakthrough infections with the SARS-CoV-2 Omicron variant and time-since-vaccination

1 Mar 2022
Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

Analyzing transcriptomic landscape of SARS-CoV-2-infected lung cells

1 Mar 2022
Epistatic shifts rationalize mutational constraints of SARS-CoV-2 receptor-binding domain

Epistatic shifts rationalize mutational constraints of SARS-CoV-2 receptor-binding domain

1 Mar 2022
Effectiveness of Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing severe SARS-CoV-2 infection

Effectiveness of Pfizer-BioNTech, Moderna, and Oxford-AstraZeneca COVID-19 vaccines in preventing severe SARS-CoV-2 infection

1 Mar 2022
Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

Effect of mRNA-based COVID-19 vaccination in multiple myeloma patients

1 Mar 2022
Study identifies olfactory dysfunction as an early symptom of COVID-19

Study identifies olfactory dysfunction as an early symptom of COVID-19

1 Mar 2022
Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

Study finds MK-4482 inhibits replication of multiple SARS-CoV-2 variants of concern in Syrian hamster COVID-19 model

1 Mar 2022

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback